Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital roofing marketplace connecting homeowners with vetted contractors; $21M Series A with 650% growth and $10.5M revenue competing with Angi for the fragmented home roofing market.
Remi is a digital roofing marketplace that connects homeowners with vetted contractors for roofing replacement and repair — digitizing the historically fragmented and opaque roofing industry by providing homeowners with instant quotes, contractor vetting, project management tools, and financing options through a single platform. Founded in 2022 in Lehi, Utah and backed by Y Combinator, Remi raised $21.5 million including a $21 million Series A led by Pelion Venture Partners in August 2024, achieving $10.5 million in revenue in 2024 with 650% growth and 140 employees.\n\nRemi's marketplace workflow allows homeowners to submit their address, receive an AI-generated estimate from aerial and property data, get matched with vetted local roofing contractors, compare proposals, and manage the project through completion — with financing options embedded for homeowners who need to fund emergency or planned roof replacements. Roofing is one of the most significant home expenses ($10,000-30,000) and a market with high consumer anxiety: finding a reliable contractor, avoiding scams, and managing insurance claims are all pain points Remi addresses through its platform approach.\n\nIn 2025, Remi competes in the home improvement marketplace market with Thumbtack (general home services), Angi (formerly Angie's List), GAF (roofing manufacturer with a contractor network), and regional roofing software platforms for the homeowner-contractor matching workflow. The residential roofing market generates $50+ billion annually in the US — it's one of the largest home improvement categories but one of the least digitized. Remi's 650% growth suggests strong product-market fit for the digital roofing marketplace model. The 2025 strategy focuses on expanding the contractor network across more geographic markets, growing the embedded financing product, and adding solar and other rooftop product categories to increase the lifetime value of each homeowner relationship.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.